135
Participants
Start Date
February 27, 2007
Primary Completion Date
January 28, 2008
Study Completion Date
January 28, 2008
placebo
placebo, oral, tablets, once daily, for 28 days
PF-00489791
PF-00489791 20 mg titrated to 40 mg, oral, tablets, once daily, for 28 days
PF-00489791
PF-00489791 4 mg, oral, tablets, once daily, for 28 days
PF-00489791
PF-00489791 10 mg, oral, tablets, once daily, for 28 days
Piedmont Medical Research Associates, Winston-Salem
Triangle Medical Research Associates, LLC, Cary
Triangle Medical Research Associates, Raleigh
Triangle Medical Research, Raleigh
Medical Research Associates of Charlotte, Inc, Charlotte
Jacksonville Center for Clinical Research, Jacksonville
Andres Patron, DO, PA, Pembroke Pines
Clinical Research Associates Incorporated, Nashville
New Orleans Center for Clinical Research, Knoxville
Volunteer Research Group, Knoxville
Riser Medical Associates, Picayune
Commonwealth Biomedical Research, LLC, Madisonville
Sterling Research Group limited, Cincinnati
Twin Cities Clinical Research, Brooklyn Center
Midwest Internists Clinical Research, P.C., St Louis
National Research Institute, Los Angeles
Apex Research Institute, Santa Ana
Orange County Research Center, Tustin
University of Connecticut Health Center, Farmington
Chase Medical Research, LLC, Waterbury
Lead Sponsor
Pfizer
INDUSTRY